| 1 |
2020 |
A Tale of Three Rarities: Secondary Amyloid A (AA) Amyloidosis Caused by Recurrent Sialadenitis and Complicated by Pulmonary Hypertension and Adrenal Insufficiency. |
--- |
| 2 |
2020 |
Amyloid A amyloidosis in a patient with Caplan's syndrome, with special reference to genetic predisposition. |
RA, SAA |
| 3 |
2020 |
Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy. |
HCM |
| 4 |
2020 |
Cervical cancer of the uterus complicated by renal AA amyloidosis. |
--- |
| 5 |
2020 |
In vitro and ex vivo expression of serum amyloid A3 in mouse lung epithelia. |
IHC, LPS, LTA, SAA |
| 6 |
2020 |
Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever. |
--- |
| 7 |
2020 |
Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review. |
FMF, RA |
| 8 |
2020 |
Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. |
GLS, LV, PW |
| 9 |
2020 |
Systemic amyloid A (AA) amyloidosis in the Bengalese finch (Lonchura striata var. domestica). |
--- |
| 10 |
2020 |
Systemic Amyloid A Amyloidosis in Stejneger's Beaked Whales (Mesoplodon stejnegeri). |
--- |
| 11 |
2019 |
A case of protein-losing gastroenteropathy caused by systemic AA amyloidosis secondary to undifferentiated carcinoma of unknown primary origin. |
--- |
| 12 |
2019 |
Allelic Diversity in the Serum Amyloid A2 Gene and Amyloid A Amyloidosis in a Breeding Colony of Zebra Finches (Taeniopygia guttata). |
--- |
| 13 |
2019 |
An Unusual Case of Acute Cholecystitis with Amyloidosis: A Case Report and Literature Review. |
--- |
| 14 |
2019 |
Experimental model of oral transmissible AA amyloidosis in quails. |
--- |
| 15 |
2019 |
Familial Mediterranean fever-associated renal amyloidosis: case report and review of the literature. |
FMF |
| 16 |
2019 |
Localized Amyloidosis of the Upper Aerodigestive Tract: Complex Analysis of the Cellular Infiltrate and the Amyloid Mass. |
APC, apoA-I, apoA-IV, IHC, LC, mRNA-ISH, PA |
| 17 |
2019 |
Modelling disease risk for amyloid A (AA) amyloidosis in non-human primates using machine learning. |
SAA |
| 18 |
2019 |
Morphological and primary structural consistency of fibrils from different AA patients (common variant). |
SAA, TEM |
| 19 |
2019 |
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. |
AKI, ATIN, CPIs, GN, IgA |
| 20 |
2019 |
Schnitzler syndrome. |
IL |
| 21 |
2019 |
[Schnitzler syndrome]. |
IL |
| 22 |
2018 |
'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. |
PWID, SSTIs |
| 23 |
2018 |
Clinical and laboratory profile of renal amyloidosis: A single-center experience. |
AL, TB |
| 24 |
2018 |
Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab. |
CD |
| 25 |
2018 |
First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan. |
TCZ |
| 26 |
2018 |
Inhibitory effect of propolis on the development of AA amyloidosis. |
SAA |
| 27 |
2018 |
Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience. |
FMF |
| 28 |
2018 |
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF. |
FMF |
| 29 |
2018 |
Relationship between Modified Body Mass Index and Prognosis of Renal Amyloid a Amyloidosis. |
BMI |
| 30 |
2018 |
Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. |
DMARDs, RA, TNFi |
| 31 |
2018 |
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
. |
MCD |
| 32 |
2018 |
Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats. |
JDCs, PCR, SAA |
| 33 |
2018 |
[Schnitzler syndrome]. |
IL |
| 34 |
2017 |
A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis. |
AL, DAPI |
| 35 |
2017 |
Amyloid A (AA) amyloidosis in CByB6 mice: a model to study gastrointestinal amyloidosis. |
--- |
| 36 |
2017 |
Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice. |
IL-1raKO, SAA |
| 37 |
2017 |
Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS). |
AL, CT, GIT, Ig, LC-MGUS, LC-MGUS, MGUS |
| 38 |
2017 |
Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis. |
CR, CRP, LYVE-1, non-CR, RA |
| 39 |
2017 |
Experimental induction of chicken amyloid A amyloidosis in white layer chickens by inoculation with inactivated vaccines. |
SAA |
| 40 |
2017 |
Gastrointestinal Tract Amyloidosis Presenting With Pneumatosis Intestinalis. |
AL |
| 41 |
2017 |
Identification of a Unique Amyloid Sequence in AA Amyloidosis of a Pig Associated With Streptococcus Suis Infection. |
SAA2 |
| 42 |
2017 |
Influence of C-terminal truncation of murine Serum amyloid A on fibril structure. |
SAA |
| 43 |
2017 |
Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. |
AL |
| 44 |
2017 |
Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis. |
Ccr, eGFR, GBM, SBP |
| 45 |
2017 |
Spontaneous, Experimentally Induced, and Transmissible AA Amyloidosis in Japanese Quail ( Coturnix japonica). |
LPS |
| 46 |
2017 |
Systemic AA amyloidosis in the red fox (Vulpes vulpes). |
--- |
| 47 |
2017 |
Systemic Amyloidosis in an African Tiger Snake (Telescopus semiannulatus). |
--- |
| 48 |
2017 |
The N-terminal region of serum amyloid A3 protein activates NF-kappaB and up-regulates MUC2 mucin mRNA expression in mouse colonic epithelial cells. |
MUC2, rSAA1, SAA |
| 49 |
2017 |
[A Case of Hemodialysis-Associated Pelvic Amyloidoma Mimicking Renal Cancer-Associated Etiology]. |
--- |
| 50 |
2016 |
Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy. |
HIDS |
| 51 |
2016 |
Amyloidosis in a Captive Zebra Finch (Taeniopygia guttata) Research Colony. |
--- |
| 52 |
2016 |
Carbamylation of the amino-terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model. |
SAA |
| 53 |
2016 |
Comparative Analysis of Outcomes of Kidney Transplantation in Patients With AA Amyloidosis and Chronic Glomerulonephritis. |
CGN |
| 54 |
2016 |
Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. |
AL, OR |
| 55 |
2016 |
Detection of AA76, a Common Form of Amyloid A Protein, as a Way of Diagnosing AA Amyloidosis. |
anti-AA76, SAA |
| 56 |
2016 |
Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis. |
CRP, DAS, HD, RA |
| 57 |
2016 |
Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice. |
SAA |
| 58 |
2016 |
Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. |
HS |
| 59 |
2016 |
Serum Amyloid A Protein Concentration in Blood is Influenced by Genetic Differences in the Cheetah (Acinonyx jubatus). |
SAA |
| 60 |
2016 |
Serum amyloid A1: Structure, function and gene polymorphism. |
HDL, SAA, SAA1.1-SAA1.5, SNP |
| 61 |
2016 |
Severe hidradenitis suppurativa complicated by renal AA amyloidosis. |
HS |
| 62 |
2016 |
Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma. |
ccRCC, HR |
| 63 |
2016 |
Studies on the potential risk of amyloidosis from exposure to silk fibroin. |
SF |
| 64 |
2016 |
Systemic Amyloid A Amyloidosis in Island Foxes (Urocyon littoralis): Severity and Risk Factors. |
ORs, SAA |
| 65 |
2015 |
Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome. |
CD |
| 66 |
2015 |
Effect of heating on the stability of amyloid A (AA) fibrils and the intra- and cross-species transmission of AA amyloidosis. |
TEM |
| 67 |
2015 |
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. |
FMF, SHARE |
| 68 |
2015 |
Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis. |
AFib, GHA |
| 69 |
2015 |
Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A. |
SAA |
| 70 |
2015 |
Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. |
AEF, IL |
| 71 |
2015 |
Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case. |
AL |
| 72 |
2015 |
Prevalence of amyloid deposition in mature healthy chickens in the flock that previously had outbreaks of vaccine-associated amyloidosis. |
--- |
| 73 |
2015 |
Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats. |
SAA |
| 74 |
2015 |
Risk factors for AA amyloidosis in Germany. |
FMF |
| 75 |
2015 |
Secondary renal amyloidosis in a patient of pulmonary tuberculosis and common variable immunodeficiency. |
CVID, ESR, PAS |
| 76 |
2015 |
Structural studies of the C-terminal 19-peptide of serum amyloid A and its Pro → Ala variants interacting with human cystatin C. |
hCC, HS, SAA |
| 77 |
2014 |
Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis. |
ABT, RA |
| 78 |
2014 |
Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. |
FMF |
| 79 |
2014 |
Amyloid A amyloidosis with subcutaneous drug abuse. |
SAA |
| 80 |
2014 |
Amyloid A amyloidosis: frequently neglected renal disease in injecting drug users. |
--- |
| 81 |
2014 |
Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. |
SAA, TCZ, TNF |
| 82 |
2014 |
Divergent effect of glycosaminoglycans on the invitro aggregation of serum amyloid A. |
GAG, SAA |
| 83 |
2014 |
Novel styrylbenzene derivatives for detecting amyloid deposits. |
FAP, PET, SSA |
| 84 |
2014 |
Outcome of 121 patients with renal amyloid a amyloidosis. |
--- |
| 85 |
2014 |
Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes. |
SAA |
| 86 |
2014 |
Red cell distribution width and mean platelet volume in amyloidosis. |
ESR, MPV, PLT, RDW |
| 87 |
2014 |
Serum amyloid A and Omentin levels in acute appendicitis: a preliminary study for a novel diagnostic approach. |
--- |
| 88 |
2014 |
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis. |
RA, TCZ |
| 89 |
2014 |
Systemic AA amyloidosis: epidemiology, diagnosis, and management. |
AL |
| 90 |
2014 |
Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis. |
IL-6, RA |
| 91 |
2014 |
Transmission of systemic AA amyloidosis in animals. |
SAA |
| 92 |
2013 |
AA amyloid nephropathy with predominant vascular deposition in Crohn's disease. |
CD |
| 93 |
2013 |
AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab. |
IL-6 |
| 94 |
2013 |
AA amyloidosis in vaccinated growing chickens. |
--- |
| 95 |
2013 |
Characterization of the oligomerization and aggregation of human Serum Amyloid A. |
hSAA1.1, SAA |
| 96 |
2013 |
Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis. |
ANOVA, RA |
| 97 |
2013 |
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. |
--- |
| 98 |
2013 |
Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium. |
PBMC, SAA |
| 99 |
2013 |
Interaction of serum amyloid A with human cystatin C--assessment of amino acid residues crucial for hCC-SAA formation (part II). |
hCC, RA, SAA |
| 100 |
2013 |
Pathogenetic mechanisms of amyloid A amyloidosis. |
SAA |
A Search Service for Abbreviation / Long Form
